Paul Negulescu, Cahalan Lab postdoc alumnus, now at Vertex Inc, 2024 Breakthrough Prize for development of effective drugs to treat cystic fibrosis. Posted: 2024-01-12 Source: News Type: Features & Briefs share Paul Negulescu, Cahalan Lab postdoc alumnus, now at Vertex Inc, 2024 Breakthrough Prize for development of effective drugs to treat cystic fibrosis. Media Contacts Matt Miller Director mrmille2@uci.edu Communications & PR Office Related Faculty/Staff Michael Cahalan, PhD Distinguished Professor — Physiology & Biophysics